Anritsu Corporation (AITUY)

Theseus Pharmaceuticals Revenue

Anritsu had revenue of 23.62B JPY in the quarter ending June 30, 2025, a decrease of -6.38%. This brings the company's revenue in the last twelve months to 111.37B, down -0.95% year-over-year. In the fiscal year ending March 31, 2025, Anritsu had annual revenue of 112.98B with 2.75% growth.

• Revenue (ttm): 111.37B JPY
• Revenue Growth: -0.95%
• P/S Ratio: 1.94
• Revenue / Employee: 28.08M JPY
• Employees: 3,966
• Market Cap: 1.50B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	112.98B	3.03B	2.75%
Mar 31, 2024	109.95B	-967.00M	-0.87%
Mar 31, 2023	110.92B	5.53B	5.25%
Mar 31, 2022	105.39B	-552.00M	-0.52%
Mar 31, 2021	105.94B	-1.08B	-1.01%